Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Norepinephrine (NE) signaling in vascular smooth muscle cells (VSMCs) is a complex process involving adrenergic receptor activation, intracellular signaling cascades, and metabolic pathways. NE primarily mediates vasoconstriction and influences cellular metabolism, promoting VSMC proliferation, migration, and phenotypic switching. Dysregulation of NE signaling contributes to the pathogenesis of hypertension, atherosclerosis, and other vascular diseases. Therapeutic interventions targeting this pathway aim to modulate adrenergic receptor activation, arachidonic acid metabolism, and extracellular vesicle-mediated communication to restore normal vascular function.
Varies depending on the specific target (e.g., receptor antagonism, enzyme inhibition). General mechanisms involve modulating adrenergic receptor activation, inhibiting arachidonic acid metabolism, or interfering with extracellular vesicle signaling.
5 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Norepinephrine Signaling in Vascular Smooth Muscle Cells (NE Signaling in VSMCs).